ArticleThe European respiratory journal2022

Wider access to quality-assured rifapentine-based regimens is needed to accelerate tuberculosis prevention and care globally.

Tiziana Masini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.